Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

Also called NCT02437084

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 115 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02437084
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02437084. Allocation not applicable; no masking; primary purpose treatment. Start 2015-05 (actual); primary completion 2020-02 (actual). Results posted on 2021-04-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Condition
Hyperlipidemia
Intervention (Drug)
Atorvastatin
Lead sponsor
Stanford University (class: other)
Collaborator
Doris Duke Charitable Foundation (class: other)

Record details

Record id
cardio:ct-nct02437084
Content hash
a3d585eb30a3bf5b0d1dec4787793d91751b2ae663d83de2c890876081ad944b